Patienter med kronisk hepatitis B eller C, der har fået antiretroviral kombinationsbehandling, har større risiko for at få svære og potentielt fatale leverbivirkninger.
Patients with chronic hepatitis B or C and treated with combination anti-retroviral therapy are at an increased risk for severe and potentially fatal hepatic adverse events.